Novavax (NVAX) Non-Current Debt (2010 - 2015)
Novavax (NVAX) recorded quarterly Non-Current Debt of $45000.0 in Q3 2015, down 69.8% quarter-over-quarter from $149000.0 in Q2 2015.
Novavax (NVAX) Non-Current Debt (2010 - 2015) Analysis & Trends
Novavax's Non-Current Debt history runs 6 years deep, the most recent figure standing at $45000.0 for Q3 2015.
- In Q3 2015, Non-Current Debt changed N/A year-over-year to $45000.0; the TTM figure through Sep 2015 stood at $45000.0 (changed N/A YoY), while the FY2014 annual figure was $395000.0, down 60.66% from the prior year.
- Non-Current Debt was $45000.0 for Q3 2015 at Novavax, down from $149000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q2 2013 to a low of $45000.0 in Q3 2015.
- Historically, Non-Current Debt has averaged $659250.0 across 5 years, with a median of $400000.0 in 2012.
- The sharpest annual moves came in 2013 and 2015: Non-Current Debt jumped 313.25% in 2013, then slumped 70.73% in 2015.
- A 5-year view of Non-Current Debt shows it stood at $300000.0 in 2011, then surged by 151.0% to $753000.0 in 2012, then surged by 33.33% to $1.0 million in 2013, then plunged by 60.66% to $395000.0 in 2014, then plunged by 88.61% to $45000.0 in 2015.
- The last three Non-Current Debt figures came in at $45000.0 (Q3 2015), $149000.0 (Q2 2015), and $252000.0 (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 45,000.00 |
| Sep 30, 2015 | 45,000.00 |
| Jun 30, 2015 | 149,000.00 |
| Jun 30, 2015 | 149,000.00 |
| Mar 31, 2015 | 252,000.00 |
| Mar 31, 2015 | 252,000.00 |
| Dec 31, 2014 | 395,000.00 |
| Dec 31, 2014 | 395,000.00 |
| Mar 31, 2014 | 861,000.00 |
| Mar 31, 2014 | 861,000.00 |
| Dec 31, 2013 | 1.00 Mn |
| Dec 31, 2013 | 1.00 Mn |
| Sep 30, 2013 | 1.65 Mn |
| Sep 30, 2013 | 1.65 Mn |
| Jun 30, 2013 | 1.65 Mn |
| Jun 30, 2013 | 1.65 Mn |
| Mar 31, 2013 | 1.29 Mn |
| Mar 31, 2013 | 1.29 Mn |
| Dec 31, 2012 | 753,000.00 |
| Dec 31, 2012 | 753,000.00 |